| Pharmaceutical active ingredients: |
| Doxorubicin Hydrochloride |
| Available forms, composition and doses of Fauldoxo: |
| N / A |
| Fauldoxo medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01DB01 - Doxorubicin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Faulding |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Doxtie | Doxorubicin Hydrochloride | Armstrong Laboratorios de Mexico; Bioprofarma |
| Doxulip | Doxorubicin Hydrochloride | United Biotech |
| Duxocin | Doxorubicin Hydrochloride | Biochem Pharmaceutical Industries |
| Ebedoxo | Doxorubicin Hydrochloride | Ebewe; Pharmaforte |
| Farmiblastina | Doxorubicin Hydrochloride | Kenfarma |
| Flavicina | Doxorubicin Hydrochloride | Pfizer |
| Ifadox | Doxorubicin Hydrochloride | Andromaco Industria Farmaceutica; Mayne Pharma |
| K.U. Doxorubicin | Doxorubicin Hydrochloride | Korea United Pharmaceutical; Kyowa Hakko |
| Myocet | Doxorubicin Hydrochloride | Cephalon; Draxis Health; Elan Pharmaceuticals; Esteve Farma; Segix Italia; Sopherion Therapeutics; Wyeth; Zeneus Pharma |
| Naprodox | Doxorubicin Hydrochloride | Miracalus Pharma |